Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
KEY FINDINGS BAR (8 stat cards) STAT 1: $150B - projected global category size by 2030 STAT 2: ~58% - of total category AI citation share captured by six pharma brands STAT 3: 2 - companies (Novo Nordisk and Eli Lilly) own nearly 100% of GLP-1 citations STAT 4: ~13% - AI Overview trigger rate on health queries, highest of any consumer category STAT 5: 60-70% - share of "best diet app" AI answers citing MyFitnessPal first STAT 6: 200M+ - registered MyFitnessPal user base, the informational moat behind its citation lock STAT 7: 60+ - consumer prompts tracked across ChatGPT, Claude, Perplexity, and Google AI Overviews to build the index STAT 8: 25 - brands ranked, with the remaining ~11% citation share split across ranks 16-25 and unranked brands THE TOP 15 BY AI CITATION SHARE Estimated share of citations across 60+ weight-loss-related consumer prompts run through ChatGPT, Claude, Perplexity, and Google AI Overviews, Q1 2026
It's bio stimulatory which means it triggers your body to produce collagen in the tissue
In one, filed against a company selling compounded GLP-1s online, it alleged that passing compounded drugs off as having identical active ingredients as its products was not merely deceptiveits dangerous. Telehealth providers and compounding pharmacies that are claiming to offer or sell unapproved compounded products claiming to contain semaglutide are sourcing their ingredients from entities other than Novo Nordisk, Novo Nordisk spokesperson Jamie Bennett told WIRED
It can be associated with the lack of B12 and iron deficiencies
Vallet-Reg, M., Colilla, M., Izquierdo-Barba, I
Glycine helps redirect that search toward fat stores instead
